MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center – located in Houston, TX – is one of the largest cancer centers in the world and one of the nation’s top ranked hospitals for cancer care according to U.S. News & World Report’s “Best Hospitals” survey. MD Anderson was created in 1941 as one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of the 51 National Cancer Institute-designated comprehensive cancer centers.
Dr. Loretta Nastoupil, an Associate Professor in the Lymphoma – Myeloma department of the Division of Cancer Medicine, serves as the Principal Investigator for the LEO consortium at MD Anderson. Dr. Nastoupil is the director of the Lymphoma Outcomes Database at MD Anderson and has extensive experience examining disparities in lymphoma survival to identify opportunities to design and implement clinical trials aimed at improving outcomes for lymphoma patients.
